[Source:  MobiHealthNews]

EarliTec Diagnostics announced it has received FDA 510(k) clearance for a device that helps clinicians identify autism spectrum disorder for children between the ages of 16 and 30 months old.

The tool, called EarliPoint Evaluation, uses eye-tracking technology to monitor a child’s looking behavior while they watch short videos of other children interacting with one another. The technology measures focus and responsiveness, which can be compared against age-expected metrics.

Read the Rest of this Article on MobiHealthNews